ক্রিপ্টোকারেন্সি লবি গ্রুপ এসইসি বনাম রিপলের এক্সআরপি মামলার বিচার করার জন্য আদালতের অনুমোদন পেয়েছে

Cryptocurrency lobby group Chamber of Digital Commerce (CDC) has received approval from a U.S. federal court to be an amicus curiae (Latin for friend of court) in the মামলা that the U.S. Securities and Exchange Commission (SEC) filed in 2020 against Ripple Labs.

সম্পর্কিত নিবন্ধটি দেখুন: XRP মামলায় SEC-এর ত্রাণ পরামর্শের প্রতি প্রবল আপত্তি

দ্রুত ঘটনা

• Judge Analisa Torres of U.S. District Court for the Southern District of New York on Wednesday মঞ্জুর the CDC’s motion for leave to file an amicus curiae brief, which was then পেশ একই দিনে.
• সিডিসি গত সপ্তাহে ড that it does not take a view in its brief on whether Ripple’s XRP sales are securities transactions in the brief, but it lays out the applicable legal precedent for the initial offering of digital assets and “makes the court aware that no federal law or regulation governs the legal characterization of a digital asset recorded on a blockchain.”
• An আমিন is typically filed by a person or organization that is not a party to a case but would petition the court for permission to submit a brief intending to influence the court’s decision.
• 2020 ডিসেম্বর, এসইসি একটি মামলা দায়ের against Ripple alleging that its sale of XRP – the native token of XRP Ledger that powers Ripple’s payment network – constituted an offering of unregistered securities worth over US$1.38 billion. The SEC also named Ripple’s executive chairman Chris Larsen and CEO Brad Garlinghouse as co-defendants for allegedly aiding and abetting Ripple’s moves.
• On Tuesday, Ripple objected to the SEC’s suggestion that it may seek additional time and pages if other amici curiae submit briefs, and said the SEC’s reaction is “yet another transparent attempt to further delay resolution of this case and the Court should reject it.”

সম্পর্কিত নিবন্ধটি দেখুন: SEC, Ripple XRP মামলার গতি বাড়ানোর প্রয়াসে সারসংক্ষেপের রায় চায়